SUTRO BIOPHARMA, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-19.7M | $1.7M |
| Depreciation & Amortization | $5.0M | $5.7M |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $1.4M | $968.0K |
| Net Cash from Operating Activities | $-37.1M | $-13.2M |
| Investing Activities | ||
| Capital Expenditures | $3.3M | $4.4M |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $32.6M | $9.6M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $14.6M | $177.0K |
| Net Change in Cash | $10.2M | $-3.4M |
| Free Cash Flow | $-40.4M | $-17.5M |